Thomas heads corporate affairs, including marketing, communications and government affairs, for GreenLight Biosciences, a biotech company focused on cutting edge RNA research, design and manufacturing. In addition to COVID-19 vaccine candidates, GreenLight is applying RNA technology to human therapeutics (Sickle Cell Disease), animal health (protecting honey bees) and plant health (crop protection). Our goal is to use science to address humanity’s greatest challenges and my role is to engage with investors, partners, regulators, customers and the general public. Thomas joined GreenLight from The Commons Project Foundation, where as the Chief Marketing and Communications Officer he led the launch of high-profile digital services and multi-stakeholder digital initiatives aimed at mitigating the impact of the COVID pandemic by allowing people to share their health information in a privacy-preserving manner. Prior to that, he led 1,000+ member global marketing and communications teams based out of the U.S., Europe and Asia. This included Global Chair, Digital at Edelman, Global Principal for Ogilvy Consulting and Global Managing Director for Social@Ogilvy. Clients included MSD Merck, Philips, McKinsey, Nestlé and Samsung. For nearly two decades he was a foreign correspondent and columnist for The New York Times and International Herald Tribune based out of Asia, Europe and the United States, covering the 2003 SARS outbreak in Asia, rare diseases in Africa, the 2004 U.S. presidential campaign, economics and technology. A frequent public speaker, he has delivered keynote speeches at many leading events and universities, including the World Economic Forum in Davos, SXSW, Cannes Lions, DLD, Stanford University, Tokyo University and the Institut d’Etudes Politiques de Paris.